head and neck cancer

Trial combines novel therapies for head and neck cancer

Vanderbilt is launching a clinical trial that pairs an experimental vaccine with an established immunotherapy for recurrent, human papilloma virus (HPV)-related oropharyngeal cancer of the head and neck.

Study seeks to refine head and neck cancer treatment options

A new robot with a flexible camera and three different surgical instruments will allow more targeted surgeries for patients with head and neck cancers.

New robot enhances accuracy of head, neck cancer surgeries

Twenty-four hours after the administration of the study drug, catheters are inserted into the tumor and lasers emitting a wavelength of light that activates the dye molecule on the ASP-1929 are illuminated.

Photoimmunotherapy offered in clinical trial for recurrent head and neck cancer

Vanderbilt-Ingram Cancer Center is recruiting patients for a clinical trial using photoimmunotherapy for recurrent head and neck cancer.

A young doctor wrote of a life-or-death moment caring for a patient. The New England Journal of Medicine published it as a graphic novel.

A terrifying tale from her first weekend on call.

Discovery Lecture to feature head and neck cancer expert Grandis

1 2 3